Cardlytics (CDLX) Tops Q2 EPS by 159c
Get Alerts CDLX Hot Sheet
Join SI Premium – FREE
Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.81), $1.59 better than the analyst estimate of ($2.40). Revenue for the quarter came in at $36.9 million versus the consensus estimate of $36.89 million.
For earnings history and earnings-related data on Cardlytics (CDLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pharming Group N.V. (PHAR) Reports Q3 results; offers guidance
- Nomura/Instinet Starts Hindalco Industries Limited (HNDL:IN) at Buy
- Axis Capital Limited Starts Bagmane Prime Office REIT (BAGMANE:IN) at Add (2)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share